Literature DB >> 6752163

Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding.

A C Goldberg, B Trivedi, J A Delmez, H R Harter, W H Daughaday.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6752163     DOI： 10.1210/jcem-55-6-1040

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

Review 1.  Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.

Authors:  B Tönshoff; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 2.  [Principles and clinical significance of insulin-like growth factors/somatomedins].

Authors:  E Weimann; W Kiess
Journal:  Klin Wochenschr       Date:  1990-10-17

3.  Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia.

Authors:  W F Blum; M B Ranke; K Kietzmann; B Tönshoff; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

Review 4.  Pitfalls in the biochemical assessment of acromegaly.

Authors:  Pamela U Freda
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 5.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

6.  Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure.

Authors:  E M Hodson; A S Brown; L P Roy; A R Rosenberg
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

7.  Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion.

Authors:  A Masuda; T Shibasaki; M Hotta; H Suematsu; K Shizume
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

8.  Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure.

Authors:  D R Powell; R G Rosenfeld; R L Hintz
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

9.  Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.

Authors:  W H Daughaday; M Kapadia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

10.  Plasma growth hormone-binding activity is low in uraemic children.

Authors:  M C Postel-Vinay; A Tar; H Crosnier; M Broyer; R Rappaport; B Tönshoff; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.